Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer.
about
Free radicals: properties, sources, targets, and their implication in various diseasesIdentification of prolidase as a high affinity ligand of the ErbB2 receptor and its regulation of ErbB2 signaling and cell growthSerial non-invasive measurements of dermal carotenoid concentrations in dairy cows following recovery from abomasal displacementImpact of reduced levels of APE1 transcripts on the survival of patients with urothelial carcinoma of the bladder.Bladder cancer: a simple model becomes complex.Relationship of hemoxygenase-1 and prolidase enzyme activity with oxidative stress in papillary thyroid cancer.Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease.Chronic inflammation in urothelial bladder cancer.HydPred: a novel method for the identification of protein hydroxylation sites that reveals new insights into human inherited disease.Paraoxonase and arylesterase activity in bladder cancer.Association between chromosomal aberration of exfoliated bladder cells in the urine and oxidative stress in patients with bladder transitional cell carcinoma.Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer.Serum prolidase activity, oxidative stress, and antioxidant enzyme levels in patients with renal cell carcinoma.Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer.The Prolidase Activity, Oxidative Stress, and Nitric Oxide Levels of Bladder Tissues with or Without Tumor in Patients with Bladder Cancer.Oxidative Stress And Prolidase Enzyme Activity In The Pathogenesis Of Primary Varicose Veins.
P2860
Q27000071-0968A40B-2ED0-43D6-BF57-7775D8FEC26FQ33720335-4D40D237-6CDD-4574-9916-7225451ABC1FQ34464571-E9D1C0B8-EA1B-413F-B166-5ED84027F0C7Q36041736-22E5FE8A-4CA4-4DD9-AAF3-868E0FDAD784Q36108115-0103B043-E68F-4FC3-BD97-8921B05EAD33Q37357618-F9D392C8-8DDB-4B4A-A7A5-35EA3903DCF4Q38246145-851DCEE4-F485-4DFA-AC1F-C32AE68B9453Q38564597-8CBDADD7-F822-4474-841B-66257F547FF5Q39176620-B5741102-06F9-4FBF-83A9-499D3CE38CE1Q40970262-DAFCE88B-3149-445A-A967-AC23C634F2D2Q40978472-79734D1C-375D-4C54-8E18-7B8F25E771DEQ41712406-F314FE4E-E14C-4FA4-8247-70B8ED095C6DQ46988553-94F768EA-F5DA-4CD0-B9D3-3346298FC32AQ47118000-95B62008-3E26-43ED-A148-CFA038B1AB50Q47262524-6C524FE3-4381-4813-BCE7-ED71FA3EF0F8Q50026131-BA8A7DAD-003E-4E00-955C-0B52BD34DC7D
P2860
Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Serum prolidase activity, oxid ...... patients with bladder cancer.
@en
Serum prolidase activity, oxid ...... patients with bladder cancer.
@nl
type
label
Serum prolidase activity, oxid ...... patients with bladder cancer.
@en
Serum prolidase activity, oxid ...... patients with bladder cancer.
@nl
prefLabel
Serum prolidase activity, oxid ...... patients with bladder cancer.
@en
Serum prolidase activity, oxid ...... patients with bladder cancer.
@nl
P2093
P2860
P1476
Serum prolidase activity, oxid ...... patients with bladder cancer.
@en
P2093
Halit Demir
Ilhan Gecit
Kadir Ceylan
Mehmet Aslan
Mustafa Gunes
Necip Pirincci
Ramazan Esen
P2860
P2888
P304
P356
10.1007/S00432-011-1136-4
P577
2012-01-19T00:00:00Z